Unresectable Malignant Solid Neoplasm

Who we are

  • April 5, 2022
    Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
  • April 5, 2022
    Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma